Table 1.
Pathogen components present on exosomes/extracellular vesicles released from infected cells
| Pathogen | Vesicle contents | References |
|---|---|---|
| HIV | Gag proteins | 119 |
| Nef protein | 68,121,123,124 | |
| TAR transcripts | 120 | |
| EBV | Viral RNAs | 134 |
| LMP1 | 129 | |
| LMP2a | 130 | |
| CMV | Glycoprotein B | 138 |
| Hepatitis C virus | Viral RNAs | 70 |
| Viral RNA/proteins | 141,142 | |
| Envelope glycoprotein E2 | 139 | |
| HSV | Viral tegument proteins and various glycoproteins | 146 |
| Toxoplasma gondii | PAMPs | 10 |
| Leishmania mexicana | GP63 | 156 |
| Proteomic analysis | 156 | |
| Leishmania major | GP63 | 157 |
| Leishmania donovani | GP63 | 158 |
| Proteomic analysis | 155 | |
| Plasmodium yoelii | Proteomic analysis | 160 |
| Plasmodium falciparum | EBA-175, EBA-181 | 162 |
| Proteomic analysis | 162 | |
| PfPTP2 | 163 | |
| Mycobacterium tuberculosis | LAM, PIM | 10,180,181 |
| 19 kDa lipoprotein | 10 | |
| Proteomic analysis | 11 | |
| mRNA | J.S. Schorey, unpublished data | |
| Mycobacterium avium | GPLs | 182 |
| Salmonella typhimurium | LPS | 10 |
| Mycoplasma | Lethal factor | 195 |
| Proteomic analysis | 195 |